缅因州医院对Trump-era 340B毒品计划的变更提起诉讼,担心预算紧张和护理减少。 Maine hospitals sue over Trump-era 340B drug program change, fearing budget strain and reduced care.

缅因州医院,包括圣玛丽地区医疗中心(St. Mary’s Regional Medical Center)加入了一场全国性的诉讼,对特朗普政府从1月开始将340B毒品计划从预付折扣转为折扣制度的做法提出质疑。 Maine hospitals, including St. Mary’s Regional Medical Center, have joined a nationwide lawsuit challenging the Trump administration’s shift in the 340B drug program from upfront discounts to a rebate system starting in January. 医院认为,改变需要几个月内新的复杂合规,会给本已紧张的预算造成压力,扰乱现金流动,并威胁到低收入病人的护理。 The hospitals argue the change, requiring complex new compliance within months, will strain already tight budgets, disrupt cash flow, and threaten care for low-income patients. 他们警告过渡可能会危及26家缅因州医院每年节省的2.5亿美元,并破坏该方案扩大获得负担得起的药物的目标。 They warn the transition could jeopardize $250 million in annual savings for 26 Maine hospitals and undermine the program’s goal of expanding access to affordable medications. 美国医院协会和其他卫生系统敦促法院阻止这一规则,称其有害且执行不力。 The American Hospital Association and other health systems urge the court to block the rule, calling it harmful and poorly implemented. 但批评者质疑试点对脆弱民众及医院可持续性的影响。 The administration says the pilot improves accountability, but critics question its impact on vulnerable populations and hospital sustainability.